Formulation Development of Taste-Masked Rapidly Dissolving Films of Cetirizine Hydrochloride - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Formulation Development of Taste-Masked Rapidly Dissolving Films of Cetirizine Hydrochloride
The authors formulated and developed taste-masked RDFs of cetirizine hydrochloride for patients who experience difficultly in swallowing the tablet dosage form of the drug.

Pharmaceutical Technology
Volume 33, Issue 2, pp. 48-56

In vivo disintegration studies. The in vivo disintegration time was measured in six human volunteers. An RDF was placed on the tongues of the volunteers and time required for disintegration in the mouth was noted.

In vitro dissolution studies. In vitro dissolution studies were conducted using three dissolution media: distilled water (500 mL), simulated gastric fluid (900 mL), and simulated saliva (500 mL) (11). The studies were performed using USP dissolution apparatus XXIV (Electrolab, Mumbai, India) at 37 0.5 C and at 50 rpm using specified dissolution media. Each film with dimension (2 2 cm2 ) was placed on a stainless steel wire mesh with sieve opening 700 μm. The film sample placed on the sieve was submerged into dissolution media. Samples were withdrawn at 2, 5, 10, 15, 30, 60, and 120 min time intervals, filtered through 0.45-μm Whatman filter paper, and analyzed spectrophotometrically at 231 nm (UV 2450 Shimadzu Scientific Instrument, Kyoto, Japan). To maintain the volume, an equal volume of fresh dissolution medium maintained at same temperature was added after withdrawing samples. The absorbance values were converted to concentration using a standard calibration curve previously obtained by experiment. The dissolution testing studies were performed in triplicate for all the batches.

Taste evaluation. Taste acceptability was measured by a taste panel with 10 mg drug and subsequently 10-mg film sample held in the mouth for 5–10 s, then spat out, and the bitterness level was recorded (6, 14). Volunteers were asked to gargle with distilled water between the drug and sample administration. The following scale was used:

  • + = very bitter
  • ++ = moderate to bitter
  • +++ = slightly bitter
  • ++++ = tasteless or taste-masked.

Results and discussion

Fourier transfer infrared spectroscopy. FTIR spectra of the pure drug showed significant bands at 3427, 2839, 2587, 1741, and 1600 cm–1, which indicates the presence of hydroxyl, ether stretching, tertiary amine salt, carbonyl groups, and phenyl nucleus skeletal stretching, respectively, and confirms the purity of the drug.

Preliminary trials were undertaken for designing the RDF wherein the effects of various grades of HPMC namely E3, E5, and E15 LV on the characteristics of the films were assessed. All three grades were varied in a concentration range of 1–4% w/v (see Table I). The initial trials were taken to evaluate the suitability of various grades of HPMC for the formation of RDF without addition of the drug.

In vitro disintegration time studies as shown in Table I suggested that films prepared with all three grades of HPMC had in vitro disintegration time below 30 s and were therefore acceptable.

Films prepared at 1% w/v concentration with all three grades were very thin, brittle, and easily broken. Films with 2–4% w/v concentration for all three grades were clear, transparent, and easily separated. Therefore, further batches containing the drug were formulated using 2–4%w/v of HPMC E grades.

RDFs containing 200 mg HPMC E5 LV formulated with CTZ resulted in highly brittle films compared with films containing 400 mg HPMC E5 LV, which separated easily. Thus, films containing 400 mg HPMC E5 LV were further evaluated for various parameters. The reason for the brittle film formation in the presence of the drug using 200 mg HPMC E5 LV might be insufficient in the sample required for film formation. The in vitro disintegration time of batches containing 400 mg HPMC E5 LV was acceptable (45 s). Trials were also conducted with the same formulation in presence (containing 0.7 mg menthol per dose) and absence of menthol as a cooling agent and plasticizer. The in vitro dissolution study of the above batches indicated total drug release in 10 and 30 min with and without menthol respectively. Thus, the in vitro dissolution was found to be slightly extended.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here